$64.99 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About LivaNova

LivaNova PLC is a medical device company. The Company is focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems throughout the world. The Company operates through two segments: Cardiac Surgery and Neuromodulation. Its Cardiac Surgery Business Franchise (CS) is engaged in the development, production and sale of cardiac surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and other accessories used for extracorporeal circulation, systems for autologous blood transfusion and blood washing. Its Neuromodulation Business Franchise designs develops and markets neuromodulation-based medical devices for the treatment of epilepsy and difficult-to-treat depression (DTD) and obstructive sleep apnea.

Stock Analysis

last close $64.08
1-mo return 7.4%
3-mo return -0.6%
avg daily vol. 324.88T
52-week high 93.89
52-week low 56.13
market cap. $3.5B
forward pe 25.5
annual div. -
roe -2.5%
ltg forecast -
dividend yield -
annual rev. $768M
inst own. -

Subscribe now for daily local and international financial news